FORTIS · Health Care · 2026-08-21

Fortis Healthcare Ltd

Stage 3 · wk 2In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹907.1
-1.06% today
₹68,482 Cr · Large cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplant, rheumatology, thoracic surgery, transfusion medicine, urology, medical generics, endocrine surgery, and other support specialties, as well as treat infectious diseases. The company's healthcare verticals comprise hospitals, diagnostics, tertiary and quaternary care, and day care specialty facilities. Fortis Healthcare Limited was incorporated in 1996 and is based in Gurugram, India.

Visit company website →
P/E (TTM)
69.5
Forward 41.0
Earnings Growth (YoY)
+44.3%
Revenue +17.8%
ROE
+11.0%
Profit margin +11.4%
Dividend Yield
0.10%
P/B 7.3
vs 52W High
-17.4%
₹788.8 lo₹1,097.9 hi
17.4% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 2
1w13w26w
Week 2 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-1.1%
200 DMA: ₹917.3 · sloping down
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.55x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↓
MA20 rolling over · -2.2% vs MA50 -1.4%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
Sector has 84 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Industry has 15 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 39w
S2 41w
S2 32w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 4w → S2 39w → S3 5w → S2 41w → S3 10w → S2 32w → S3 12w → S2 1w → S1 2w → S4 5w → S1 6w → S2 8w → S3 1w current
Total tracked: 167 weeks across 13 stage runs.
1M
-3.9%
3M
-5.5%
6M
-0.9%
YTD
+2.6%
1Y
-4.1%
Scan Membership
Breakout Watch
Latest: 2026-06-15
4 appearances in last 60 days. First seen: 2024-04-29.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S3
Wk 2 · Vol —x
2026-08-20S3
Wk 2 · Vol —x
2026-08-19S3
Wk 2 · Vol —x
2026-08-18S3
Wk 1 · Vol —x
2026-08-17S3
Wk 1 · Vol —x
2026-08-14S3
Wk 1 · Vol —x
2026-08-13S3
Wk 1 · Vol —x
2026-08-12S32→3
Wk 1 · Vol —x
2026-08-11S2
Wk 9 · Vol —x
2026-08-10S2
Wk 8 · Vol —x
2026-08-07S2
Wk 8 · Vol —x
2026-08-06S2
Wk 8 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹949.6
200 DMA
₹917.3
52W High
₹1,097.9
52W Low
₹788.8
5D Low
₹907.1
Resistance levels (recent highs)
20d High
₹955.2
60d High
₹990.4
120d High
₹990.4
250d High
₹1,097.9
Next resistance
+5.3%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.